Delivery Order SPE2DB24D1205-SPE2DB25FDASP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,879.12 by the Defense Logistics Agency on October 28, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract is a firm fixed price delivery order with an ultimate completion date of November 19, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 18, 2025. The award supports the company's role as a critical pharmaceutical distributor within the federal medical supply chain, with performance originating from the vendor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $9,374.36 on August 18, 2025, with completion scheduled for September 9, 2025. The contract covers the supply of Tezspire 210 mg/1.91 mL pen auto-injectors and was funded through the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order represents a non-set-aside award, indicating open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors, with a ceiling value of $2,343.59. This is a firm fixed-price delivery order with no set-aside designation, requiring completion by November 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This non-set-aside, firm fixed-price contract is classified as a delivery order with an ultimate completion date of October 21, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract calls for delivery of Tezspire 210 mg/1.91 ml pen injectors, a specialty pharmaceutical product for respiratory conditions. This is a firm fixed-price, competitively awarded delivery order with no...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors valued at $7,030.77, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with the Defense Logistics Agency. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed-price delivery order with a ceiling value of $2,469.78 and an ultimate completion date of December 17, 2025. The contract was competitively awarded with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency on August 22, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 15, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award involves no set-aside designation, reflecting the company's competitive standing in federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This firm fixed price delivery order, valued at $4,939.58, is scheduled for completion by December 17, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDASPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $46,871.80 by the Defense Logistics Agency on September 19, 2025. The contract calls for the supply of Tezspire 210 mg/1.91 mL pen injectors and is expected to be completed by October 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement for pharmaceutical products. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The Tezspire delivery exemplifies the company's role as a critical vendor for federal medical procurement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.9k | 9/19/25 |